MANNELLA, IOLE
MANNELLA, IOLE
SCIENZA E TECNOLOGIA DEL FARMACO
A new generation of AKR1C3 inhibitors on the horizon: the 3- hydroxybenzazole approach to target prostate cancer
2023-01-01 Chiara Vigato, Agnese Chiara Pippione, Stefano Sainas, Iole Mannella, Laura Bertarini, Sandra Kovachka, Barbara Rolando, Osman Asghar Mirza, Karla Frydenvang, Francesca Spyrakis, Simonetta Oliaro-Bosso, Marco Lucio Lolli, Donatella Boschi
Exploring Novel Compounds Targeting Mycobacterium tuberculosis Dihydroorotate Dehydrogenase: SAR Analysis and Biological Activity
2024-01-01 Mannella Iole, Sainas Stefano, Gasperin Alessio, Alberti Marta, Lolli Marco Lucio, Miggiano Riccardo, Boschi Donatella
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER
2023-01-01 Agnese C. Pippione, Stefano Sainas, Chiara Vigato, Iole Mannella, Irene Castellino, Sandra Kovachka, Mariia Iakovleva, Barbara Rolando, Tomasz Wrobel, Osman A. Mirza, Karla Frydenvang, Francesca Spyrakis, Simonetta Oliaro-Bosso, Marco L. Lolli, Donatella Boschi
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role.
2024-01-01 Elena Martino, Stefano Sainas, Marta Alberti, Iole Mannella, Marta Giorgis, Paola Circosta, Donatella Boschi, Marco Lucio Lolli
Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer
2021-01-01 Agnese Chiara Pippione, Zuhal Kilic-Kurt, Stefano Sainas, Iole Mannella, Barbara Rolando, Sandra Kovachka, Francesca Spyrakis, Annamaria Buschini, Serena Montalbano, Simonetta Oliaro Bosso, Marco Lolli, Donatella Boschi
New Hydroxybenzoazole Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3): Disclosure of SAR Investigation to Target Prostate Cancer
2022-01-01 Chiara Vigato, Agnese Chiara Pippione, Iole Mannella, Mariia Iakovleva, Stefano Sainas, Simonetta Oliaro Bosso, Barbara Rolando, Sandra Kovachka, Francesca Spyrakis, Marco Lucio Lolli, Donatella Boschi
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer
2021-01-01 Mannella, Iole, Vigato, Chiara, Pasha, Rabia; Pippione Agnese Chiara, Sainas, Stefano, Oliaro Bosso Simonetta; Rolando, Barbara; Kovachka, Sandra, Spyrakis, Francesca; Boschi, Donatella, Lolli. Marco Lucio
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies
2023-01-01 Iole Mannella, Chiara Vigato, Stefano Sainas, Marco Lucio Lolli, Donatella Boschi
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies
2023-01-01 Iole Mannella, Chiara Vigato, Stefano Sainas, Marco Lucio Lolli, Donatella Boschi
OPTIMIZING SYNTHESIS AND IN VIVO EVALUATION OF MEDS433: ADVANCING TO PRECLINICAL DEVELOPMENT IN ACUTE MYELOID LEUKEMIA
2024-01-01 Iole Mannella
Scaling up synthesis and in vivo evaluation of MEDS433: a promising preclinical candidate targeting AML
2024-01-01 Iole Mannella, Stefano Sainas, Paola Circosta, Marta Giorgis, Marco Lucio Lolli, Donatella Boschi
TARGETING MYCOBACTERIUM TUBERCULOSIS DHODH: SAR ANALYSIS AND BIOLOGICAL ACRIVITY OF A NOVEL COMPOUND CLASS
2024-01-01 Mannella Iole, Sainas stefano, Alessio gasperin, Alberti Marta, Marco Lucio Lolli, Miggiano Riccardo, Boschi Donatella
TARGETING MYCOBACTERIUM TUBERCULOSIS DHODH: SAR ANALYSIS AND BIOLOGICAL ACRIVITY OF A NOVEL COMPOUND CLASS
2024-01-01 Iole Mannella, Stefano Sainas, Alessio Gasperin, Marta Alberti, Marco Lucio Lolli, Riccardo Miggiano, Donatella Boschi
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A new generation of AKR1C3 inhibitors on the horizon: the 3- hydroxybenzazole approach to target prostate cancer | 2023 | Chiara Vigato, Agnese Chiara Pippione, Stefano Sainas, Iole Mannella, Laura Bertarini, Sandra Kovachka, Barbara Rolando, Osman Asghar Mirza, Karla Frydenvang, Francesca Spyrakis, Simonetta Oliaro-Bosso, Marco Lucio Lolli, Donatella Boschi | |
Exploring Novel Compounds Targeting Mycobacterium tuberculosis Dihydroorotate Dehydrogenase: SAR Analysis and Biological Activity | 2024 | Mannella Iole, Sainas Stefano, Gasperin Alessio, Alberti Marta, Lolli Marco Lucio, Miggiano Riccardo, Boschi Donatella | |
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER | 2023 | Agnese C. Pippione, Stefano Sainas, Chiara Vigato, Iole Mannella, Irene Castellino, Sandra Kovachka, Mariia Iakovleva, Barbara Rolando, Tomasz Wrobel, Osman A. Mirza, Karla Frydenvang, Francesca Spyrakis, Simonetta Oliaro-Bosso, Marco L. Lolli, Donatella Boschi | |
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role. | 2024 | Elena Martino, Stefano Sainas, Marta Alberti, Iole Mannella, Marta Giorgis, Paola Circosta, Donatella Boschi, Marco Lucio Lolli | |
Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer | 2021 | Agnese Chiara Pippione, Zuhal Kilic-Kurt, Stefano Sainas, Iole Mannella, Barbara Rolando, Sandra Kovachka, Francesca Spyrakis, Annamaria Buschini, Serena Montalbano, Simonetta Oliaro Bosso, Marco Lolli, Donatella Boschi | |
New Hydroxybenzoazole Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3): Disclosure of SAR Investigation to Target Prostate Cancer | 2022 | Chiara Vigato, Agnese Chiara Pippione, Iole Mannella, Mariia Iakovleva, Stefano Sainas, Simonetta Oliaro Bosso, Barbara Rolando, Sandra Kovachka, Francesca Spyrakis, Marco Lucio Lolli, Donatella Boschi | |
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer | 2021 | Mannella, Iole, Vigato, Chiara, Pasha, Rabia; Pippione Agnese Chiara, Sainas, Stefano, Oliaro Bosso Simonetta; Rolando, Barbara; Kovachka, Sandra, Spyrakis, Francesca; Boschi, Donatella, Lolli. Marco Lucio | |
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies | 2023 | Iole Mannella, Chiara Vigato, Stefano Sainas, Marco Lucio Lolli, Donatella Boschi | |
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies | 2023 | Iole Mannella, Chiara Vigato, Stefano Sainas, Marco Lucio Lolli, Donatella Boschi | |
OPTIMIZING SYNTHESIS AND IN VIVO EVALUATION OF MEDS433: ADVANCING TO PRECLINICAL DEVELOPMENT IN ACUTE MYELOID LEUKEMIA | 2024 | Iole Mannella | |
Scaling up synthesis and in vivo evaluation of MEDS433: a promising preclinical candidate targeting AML | 2024 | Iole Mannella, Stefano Sainas, Paola Circosta, Marta Giorgis, Marco Lucio Lolli, Donatella Boschi | |
TARGETING MYCOBACTERIUM TUBERCULOSIS DHODH: SAR ANALYSIS AND BIOLOGICAL ACRIVITY OF A NOVEL COMPOUND CLASS | 2024 | Mannella Iole, Sainas stefano, Alessio gasperin, Alberti Marta, Marco Lucio Lolli, Miggiano Riccardo, Boschi Donatella | |
TARGETING MYCOBACTERIUM TUBERCULOSIS DHODH: SAR ANALYSIS AND BIOLOGICAL ACRIVITY OF A NOVEL COMPOUND CLASS | 2024 | Iole Mannella, Stefano Sainas, Alessio Gasperin, Marta Alberti, Marco Lucio Lolli, Riccardo Miggiano, Donatella Boschi |